Find Research Outputs

Search in all content

Filters for Research Output

Search concepts
Selected Filters

Publication Year

  • 2020
  • 2019
  • 2018
  • 2017
  • 2016

Author

  • David R Gandara
2020

Efficacy of chemotherapy and atezolizumab in patients with non-small-cell lung cancer receiving antibiotics and proton pump inhibitors: pooled post hoc analyses of the OAK and POPLAR trials

imCORE working group of early career investigators, Apr 2020, In : Annals of Oncology. 31, 4, p. 525-531 7 p.

Research output: Contribution to journalArticle

Open Access
7 Scopus citations

Intravenous 5-fluoro-2′-deoxycytidine administered with tetrahydrouridine increases the proportion of p16-expressing circulating tumor cells in patients with advanced solid tumors

Coyne, G. O. S., Wang, L., Zlott, J., Juwara, L., Covey, J. M., Beumer, J. H., Cristea, M. C., Newman, E. M., Koehler, S., Nieva, J. J., Garcia, A. A., Gandara, D. R., Miller, B., Khin, S., Miller, S. B., Steinberg, S. M., Rubinstein, L., Parchment, R. E., Kinders, R. J., Piekarz, R. L. & 3 others, Kummar, S., Chen, A. P. & Doroshow, J. H., May 1 2020, In : Cancer Chemotherapy and Pharmacology. 85, 5, p. 979-993 15 p.

Research output: Contribution to journalArticle

Open Access

Molecular Landscape of BRAF-Mutant NSCLC Reveals an Association Between Clonality and Driver Mutations and Identifies Targetable Non-V600 Driver Mutations

Negrao, M. V., Raymond, V. M., Lanman, R. B., Robichaux, J. P., He, J., Nilsson, M. B., Ng, P. K. S., Amador, B. E., Roarty, E. B., Nagy, R. J., Banks, K. C., Zhu, V. W., Ng, C., Chae, Y. K., Clarke, J. M., Crawford, J. A., Meric-Bernstam, F., Ou, S. H., Gandara, D. R., Heymach, J. V. & 2 others, Bivona, T. G. & McCoach, C. E., 2020, (Accepted/In press) In : Journal of Thoracic Oncology.

Research output: Contribution to journalArticle

Open Access

Spectrum of driver mutations and clinical impact of circulating tumor DNA analysis in non–small cell lung cancer: Analysis of over 8000 cases

Mack, P. C., Banks, K. C., Espenschied, C. R., Burich, R. A., Zill, O. A., Lee, C. E., Riess, J. W., Mortimer, S. A., Talasaz, A. A., Lanman, R. B. & Gandara, D. R., Jan 1 2020, (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations
2019

A phase II study of the orally administered negative enantiomer of gossypol (AT-101), a BH3 mimetic, in patients with advanced adrenal cortical carcinoma

Xie, H., Yin, J., Shah, M. H., Menefee, M. E., Bible, K. C., Reidy-Lagunes, D., Kane, M. A., Quinn, D. I., Gandara, D. R., Erlichman, C. & Adjei, A. A., Jan 1 2019, In : Investigational New Drugs.

Research output: Contribution to journalArticle

2 Scopus citations

Challenges and approaches to implementing master/basket trials in oncology

Burd, A., Schilsky, R. L., Byrd, J. C., Levine, R. L., Papadimitrakopoulou, V. A., Herbst, R. S., Redman, M. W., Druker, B. J. & Gandara, D. R., Jul 23 2019, In : Blood Advances. 3, 14, p. 2237-2243 7 p.

Research output: Contribution to journalArticle

Open Access
3 Scopus citations

Comparative Efficacy of Second- and Subsequent-line Treatments for Metastatic NSCLC: A Fractional Polynomials Network Meta-analysis of Cancer Immunotherapies

Schulz, C., Gandara, D. R., Berardo, C. G., Rosenthal, R., Foo, J., Morel, C., Ballinger, M., Watkins, C. & Chu, P., Jan 1 2019, (Accepted/In press) In : Clinical lung cancer.

Research output: Contribution to journalArticle

2 Scopus citations

CT Volumetry and Basic Texture Analysis as Surrogate Markers in Advanced Non–small-cell Lung Cancer

Owen, B., Gandara, D., Kelly, K., Moore, E., Shelton, D. & Knollmann, F., Jan 1 2019, (Accepted/In press) In : Clinical lung cancer.

Research output: Contribution to journalArticle

EBV-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma Response to PD-L1 Blockade

Narayanan, A., Knollmann, F. D., Walby, J. A. S., Lim, S., Gandara, D. R. & Riess, J., Jan 1 2019, (Accepted/In press) In : Clinical Lung Cancer.

Research output: Contribution to journalArticle

6 Scopus citations

IMpower030: Phase III study evaluating neoadjuvant treatment of resectable stage II-IIIB non-small cell lung cancer (NSCLC) with atezolizumab (atezo) + chemotherapy

Peters, S., Kim, A. W., Solomon, B., Gandara, D. R., Dziadziuszko, R., Brunelli, A., Garassino, M. C., Reck, M., Wang, L., To, I., Sun, S. W., Gitlitz, B. J., Sandler, A. & Rizvi, N., Apr 2019, In : Annals of Oncology. 30, p. ii30

Research output: Contribution to journalArticle

Open Access

Long-term survival in patients with advanced non–small-cell lung cancer treated with atezolizumab versus docetaxel: Results from the randomised phase III OAK study

von Pawel, J., Bordoni, R., Satouchi, M., Fehrenbacher, L., Cobo, M., Han, J. Y., Hida, T., Moro-Sibilot, D., Conkling, P., Gandara, D. R., Rittmeyer, A., Gandhi, M., Yu, W., Matheny, C., Patel, H., Sandler, A., Ballinger, M., Kowanetz, M. & Park, K., Jan 1 2019, In : European Journal of Cancer. 107, p. 124-132 9 p.

Research output: Contribution to journalArticle

22 Scopus citations

Phase 1 study of veliparib (ABT-888), a poly (ADP-ribose) polymerase inhibitor, with carboplatin and paclitaxel in advanced solid malignancies

Appleman, L. J., Beumer, J. H., Jiang, Y., Lin, Y., Ding, F., Puhalla, S., Swartz, L., Owonikoko, T. K., Donald Harvey, R., Stoller, R., Petro, D. P., Tawbi, H. A., Argiris, A., Strychor, S., Pouquet, M., Kiesel, B., Chen, A. P., Gandara, D., Belani, C. P., Chu, E. & 1 others, Ramalingam, S. S., Dec 1 2019, In : Cancer Chemotherapy and Pharmacology. 84, 6, p. 1289-1301 13 p.

Research output: Contribution to journalArticle

Open Access
7 Scopus citations
2 Scopus citations

Phase I trial of belinostat in combination with 13-cis-retinoic acid in advanced solid tumor malignancies: a California Cancer Consortium NCI/CTEP sponsored trial

Luu, T., Frankel, P., Beumer, J. H., Lim, D., Cristea, M., Appleman, L. J., Lenz, H. J., Gandara, D. R., Kiesel, B. F., Piekarz, R. L. & Newman, E. M., Dec 1 2019, In : Cancer Chemotherapy and Pharmacology. 84, 6, p. 1201-1208 8 p.

Research output: Contribution to journalArticle

SWOG S1400B (NCT02785913), a Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study)

Langer, C. J., Redman, M. W., Wade, J. L., Aggarwal, C., Bradley, J. D., Crawford, J., Stella, P. J., Knapp, M. H., Miao, J., Minichiello, K., Herbst, R. S., Kelly, K., Gandara, D. R. & Papadimitrakopoulou, V. A., Jan 1 2019, (Accepted/In press) In : Journal of Thoracic Oncology.

Research output: Contribution to journalArticle

6 Scopus citations

SWOG S1400C (NCT02154490)—A Phase II Study of Palbociclib for Previously Treated Cell Cycle Gene Alteration–Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy)

Edelman, M. J., Redman, M. W., Albain, K. S., McGary, E. C., Rafique, N. M., Petro, D., Waqar, S. N., Minichiello, K., Miao, J., Papadimitrakopoulou, V. A., Kelly, K., Gandara, D. R. & Herbst, R. S., Jan 1 2019, (Accepted/In press) In : Journal of Thoracic Oncology.

Research output: Contribution to journalArticle

8 Scopus citations

SWOG S1400D (NCT02965378), a Phase II Study of the Fibroblast Growth Factor Receptor Inhibitor AZD4547 in Previously Treated Patients With Fibroblast Growth Factor Pathway–Activated Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy)

Aggarwal, C., Redman, M. W., Lara, P. N., Borghaei, H., Hoffman, P., Bradley, J. D., Newman, A. J., Feldman, M. J., Minichiello, K., Miao, J., Mack, P. C., Papadimitrakopoulou, V. A., Herbst, R. S., Kelly, K. & Gandara, D. R., Jan 1 2019, In : Journal of Thoracic Oncology.

Research output: Contribution to journalArticle

9 Scopus citations
2018

American society of clinical oncology's global oncology leadership task force: Findings and actions

Hortobagyi, G. N., Pyle, D., Cazap, E. L., El Saghir, N. S., Shulman, L. N., Lyman, G. H., Schnipper, L. E., Adebamowo, C. A., Gandara, D. R., Vose, J., Wong, S. L. & Yu, P., Mar 1 2018, In : Journal of global oncology. 2018, 4

Research output: Contribution to journalArticle

5 Scopus citations

A model of overall survival predicts treatment outcomes with atezolizumab versus chemotherapy in non–small cell lung cancer based on early tumor kinetics

Claret, L., Jin, J. Y., Ferte, C., Winter, H., Girish, S., Stroh, M., He, P., Ballinger, M., Sandler, A., Joshi, A., Rittmeyer, A., Gandara, D. R., Soria, J. C. & Bruno, R., Jul 15 2018, In : Clinical Cancer Research. 24, 14, p. 3292-3298 7 p.

Research output: Contribution to journalArticle

13 Scopus citations

Antitumor activity of osimertinib, an irreversible mutant-selective EGFR tyrosine kinase inhibitor, in NSCLC harboring EGFR exon 20 insertions

Floc'h, N., Martin, M. J., Riess, J., Orme, J. P., Staniszewska, A. D., Menard, L., Cuomo, M. E., O'Neill, D. J., Ward, R. A., Finlay, R. M. V., McKerrecher, D., Cheng, M., Vang, D. P., Burich, R. A., Keck, J. G., Gandara, D. R., Mack, P. & Cross, D. A. E., May 1 2018, In : Molecular Cancer Therapeutics. 17, 5, p. 885-896 12 p.

Research output: Contribution to journalArticle

28 Scopus citations

A phase I trial of escalating doses of cixutumumab (IMC-A12) and sorafenib in the treatment of advanced hepatocellular carcinoma

El-Khoueiry, A. B., O'Donnell, R. T., Semrad, T., Mack, P., Blanchard, S., Bahary, N., Jiang, Y., Yen, Y., Wright, J., Chen, H., Lenz, H. J. & Gandara, D. R., Mar 8 2018, (Accepted/In press) In : Cancer Chemotherapy and Pharmacology. p. 1-7 7 p.

Research output: Contribution to journalArticle

2 Scopus citations

A phase I trial of topotecan plus tivantinib in patients with advanced solid tumors

Liu, S. V., Groshen, S. G., Kelly, K., Reckamp, K. L., Belani, C., Synold, T. W., Goldkorn, A., Gitlitz, B. J., Cristea, M. C., Gong, I-Y., Semrad, T. J., Xu, Y., Xu, T., Koczywas, M., Gandara, D. R. & Newman, E. M., Jan 1 2018, (Accepted/In press) In : Cancer Chemotherapy and Pharmacology.

Research output: Contribution to journalArticle

4 Scopus citations

Atezolizumab Treatment Beyond Progression in Advanced NSCLC: Results From the Randomized, Phase III OAK Study

Gandara, D. R., von Pawel, J., Mazieres, J., Sullivan, R., Helland, Å., Han, J. Y., Ponce Aix, S., Rittmeyer, A., Barlesi, F., Kubo, T., Park, K., Goldschmidt, J., Gandhi, M., Yun, C., Yu, W., Matheny, C., He, P., Sandler, A., Ballinger, M. & Fehrenbacher, L., Jan 1 2018, (Accepted/In press) In : Journal of Thoracic Oncology.

Research output: Contribution to journalArticle

20 Scopus citations

Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab

Gandara, D. R., Paul, S. M., Kowanetz, M., Schleifman, E., Zou, W., Li, Y., Rittmeyer, A., Fehrenbacher, L., Otto, G., Malboeuf, C., Lieber, D. S., Lipson, D., Silterra, J., Amler, L., Riehl, T., Cummings, C. A., Hegde, P. S., Sandler, A., Ballinger, M., Fabrizio, D. & 2 others, Mok, T. & Shames, D. S., Jan 1 2018, (Accepted/In press) In : Nature Medicine.

Research output: Contribution to journalArticle

243 Scopus citations

Consensus report of the 8 and 9th Weinman Symposia on Gene x Environment Interaction in carcinogenesis: novel opportunities for precision medicine

Carbone, M., Amelio, I., Affar, E. B., Brugarolas, J., Cannon-Albright, L. A., Cantley, L. C., Cavenee, W. K., Chen, Z., Croce, C. M., Andrea, A. D., Gandara, D. R., Giorgi, C., Jia, W., Lan, Q., Mak, T. W., Manley, J. L., Mikoshiba, K., Onuchic, J. N., Pass, H. I., Pinton, P. & 8 others, Prives, C., Rothman, N., Sebti, S. M., Turkson, J., Wu, X., Yang, H., Yu, H. & Melino, G., Nov 1 2018, In : Cell Death and Differentiation. 25, 11, p. 1885-1904 20 p.

Research output: Contribution to journalReview article

8 Scopus citations

Correlation of PD-L1 Expression with Tumor Mutation Burden and Gene Signatures for Prognosis in Early-Stage Squamous Cell Lung Carcinoma

Yu, H., Chen, Z., Ballman, K. V., Watson, M. A., Govindan, R., Lanc, I., Beer, D. G., Bueno, R., Chirieac, L. R., Chui, M. H., Chen, G., Franklin, W. A., Gandara, D. R., Genova, C., Brovsky, K. A., Joshi, M. B. M., Merrick, D. T., Richards, W. G., Rivard, C. J., Harpole, D. H. & 4 others, Tsao, M. S., van Bokhoven, A., Shepherd, F. A. & Hirsch, F. R., Jan 1 2018, (Accepted/In press) In : Journal of Thoracic Oncology.

Research output: Contribution to journalArticle

15 Scopus citations

CT perfusion imaging of lung cancer: benefit of motion correction for blood flow estimates

Chu, L. L., Knebel, R. J., Shay, A. D., Santos, J., Badawi, R. D., Gandara, D. R. & Knollmann, F. D., Jun 4 2018, (Accepted/In press) In : European Radiology. p. 1-7 7 p.

Research output: Contribution to journalArticle

3 Scopus citations

Current and Emergent Therapy Options for Advanced Squamous Cell Lung Cancer

Socinski, M. A., Obasaju, C., Gandara, D. R., Hirsch, F. R., Bonomi, P., Bunn, P. A., Kim, E. S., Langer, C. J., Natale, R. B., Novello, S., Paz-Ares, L., Pérol, M., Reck, M., Ramalingam, S. S., Reynolds, C. H., Spigel, D. R., Wakelee, H. & Thatcher, N., Feb 1 2018, In : Journal of Thoracic Oncology. 13, 2, p. 165-183 19 p.

Research output: Contribution to journalReview article

18 Scopus citations

Diverse EGFR Exon 20 Insertions and Co-Occurring Molecular Alterations Identified by Comprehensive Genomic Profiling of NSCLC

Riess, J., Gandara, D. R., Frampton, G. M., Madison, R., Peled, N., Bufill, J. A., Dy, G. K., Ou, S. H. I., Stephens, P. J., Mcpherson, J. D., Lara, P. N., Burich, R. A., Ross, J. S., Miller, V. A., Ali, S. M., Mack, P. & Schrock, A. B., Oct 1 2018, In : Journal of Thoracic Oncology. 13, 10, p. 1560-1568 9 p.

Research output: Contribution to journalArticle

21 Scopus citations

In search of an oncogene driver for squamous lung cancer

Gandara, D. R., Riess, J. & Lara, P. N., Sep 1 2018, In : JAMA oncology. 4, 9, p. 1197-1198 2 p.

Research output: Contribution to journalComment/debate

Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC

Rolfo, C., Mack, P., Scagliotti, G. V., Baas, P., Barlesi, F., Bivona, T. G., Herbst, R. S., Mok, T. S., Peled, N., Pirker, R., Raez, L. E., Reck, M., Riess, J., Sequist, L. V., Shepherd, F. A., Sholl, L. M., Tan, D. S. W., Wakelee, H. A., Wistuba, I. I., Wynes, M. W. & 3 others, Carbone, D. P., Hirsch, F. R. & Gandara, D. R., Jan 1 2018, (Accepted/In press) In : Journal of Thoracic Oncology.

Research output: Contribution to journalArticle

138 Scopus citations

Molecular and Immune Biomarker Testing in Squamous-Cell Lung Cancer: Effect of Current and Future Therapies and Technologies

Hirsch, F. R., Kerr, K. M., Bunn, P. A., Kim, E. S., Obasaju, C., Pérol, M., Bonomi, P., Bradley, J. D., Gandara, D. R., Jett, J. R., Langer, C. J., Natale, R. B., Novello, S., Paz-Ares, L., Ramalingam, S. S., Reck, M., Reynolds, C. H., Smit, E. F., Socinski, M. A., Spigel, D. R. & 4 others, Stinchcombe, T. E., Vansteenkiste, J. F., Wakelee, H. & Thatcher, N., Jan 1 2018, (Accepted/In press) In : Clinical Lung Cancer.

Research output: Contribution to journalArticle

2 Scopus citations

Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer

Bonomi, P. D., Gandara, D. R., Hirsch, F. R., Kerr, K. M., Obasaju, C., Paz-Ares, L., Bellomo, C., Bradley, J. D., Bunn, P. A., Culligan, M., Jett, J. R., Kim, E. S., Langer, C. J., Natale, R. B., Novello, S., Pérol, M., Ramalingam, S. S., Reck, M., Reynolds, C. H., Smit, E. F. & 5 others, Socinski, M. A., Spigel, D. R., Vansteenkiste, J. F., Wakelee, H. & Thatcher, N., Jan 1 2018, In : Annals of Oncology. 29, 8, p. 1701-1709 9 p.

Research output: Contribution to journalReview article

4 Scopus citations

Smoking, sex, and non–Small cell lung cancer: Steroid hormone receptors in tumor tissue (S0424)

Cheng, T. Y. D., Darke, A. K., Redman, M. W., Zirpoli, G. R., Davis, W., Ondracek, R. P., Bshara, W., Omilian, A. R., Kratzke, R., Reid, M. E., Molina, J. R., Kolesar, J. M., Chen, Y., MacRae, R. M., Moon, J., Mack, P., Gandara, D. R., Kelly, K., Santella, R. M., Albain, K. S. & 1 others, Ambrosone, C. B., Jan 1 2018, In : Journal of the National Cancer Institute. 110, 7, p. 734-742 9 p.

Research output: Contribution to journalArticle

7 Scopus citations

The landscape of actionable genomic alterations in cell-free circulating tumor DNA from 21,807 advanced cancer patients

Zill, O. A., Banks, K. C., Fairclough, S. R., Mortimer, S. A., Vowles, J. V., Mokhtari, R., Gandara, D. R., Mack, P., Odegaard, J. I., Nagy, R. J., Baca, A. M., Eltoukhy, H., Chudova, D. I., Lanman, R. B. & Talasaz, A. A., Aug 1 2018, In : Clinical Cancer Research. 24, 15, p. 3528-3538 11 p.

Research output: Contribution to journalArticle

72 Scopus citations

Updated Efficacy Analysis Including Secondary Population Results for OAK: A Randomized Phase III Study of Atezolizumab versus Docetaxel in Patients with Previously Treated Advanced Non–Small Cell Lung Cancer

Fehrenbacher, L., von Pawel, J., Park, K., Rittmeyer, A., Gandara, D. R., Ponce Aix, S., Han, J. Y., Gadgeel, S. M., Hida, T., Cortinovis, D. L., Cobo, M., Kowalski, D. M., De Marinis, F., Gandhi, M., Danner, B., Matheny, C., Kowanetz, M., He, P., Felizzi, F., Patel, H. & 3 others, Sandler, A., Ballinger, M. & Barlesi, F., Aug 1 2018, In : Journal of Thoracic Oncology. 13, 8, p. 1156-1170 15 p.

Research output: Contribution to journalArticle

55 Scopus citations
2017
41 Scopus citations

An Evolving Algorithm to Select and Sequence Therapies in EGFR Mutation-positive NSCLC: A Strategic Approach

Melosky, B., Popat, S. & Gandara, D. R., 2017, (Accepted/In press) In : Clinical Lung Cancer.

Research output: Contribution to journalArticle

3 Scopus citations

A Phase 1/1b Study Evaluating Trametinib Plus Docetaxel or Pemetrexed in Patients With Advanced Non–Small Cell Lung Cancer

Gandara, D. R., Leighl, N., Delord, J. P., Barlesi, F., Bennouna, J., Zalcman, G., Infante, J. R., Reckamp, K. L., Kelly, K., Shepherd, F. A., Mazieres, J., Janku, F., Gardner, O. S., Mookerjee, B., Wu, Y., Cox, D. S., Schramek, D., Peddareddigari, V., Liu, Y., D'Amelio, A. M. & 1 others, Blumenschein, G., Mar 1 2017, In : Journal of Thoracic Oncology. 12, 3, p. 556-566 11 p.

Research output: Contribution to journalArticle

15 Scopus citations
1677 Scopus citations

Cetuximab plus carboplatin and paclitaxel with or without bevacizumab versus carboplatin and paclitaxel with or without bevacizumab in advanced NSCLC (SWOG S0819): A randomised, phase 3 study

Herbst, R. S., Redman, M. W., Kim, E. S., Semrad, T., Bazhenova, L., Masters, G., Oettel, K., Guaglianone, P., Reynolds, C., Karnad, A., Arnold, S. M., Varella-Garcia, M., Moon, J., Mack, P., Blanke, C. D., Hirsch, F. R., Kelly, K. & Gandara, D. R., Jan 1 2017, (Accepted/In press) In : The Lancet Oncology.

Research output: Contribution to journalArticle

30 Scopus citations

Clinical predictors of survival in young patients with small cell lung cancer: Results from the California Cancer Registry

Lara, J. D., Brunson, A., Riess, J., Kelly, K., Lara, P. N. & Gandara, D. R., Oct 1 2017, In : Lung Cancer. 112, p. 165-168 4 p.

Research output: Contribution to journalArticle

7 Scopus citations

Double Trouble: A Case Series on Concomitant Genetic Aberrations in NSCLC

Van Der Steen, N., Mentens, Y., Ramael, M., Leon, L. G., Germonpré, P., Ferri, J., Gandara, D. R., Giovannetti, E., Peters, G. J., Pauwels, P. & Rolfo, C., 2017, (Accepted/In press) In : Clinical Lung Cancer.

Research output: Contribution to journalArticle

7 Scopus citations

Efficacy and Safety Results From a Phase II, Placebo-Controlled Study of Onartuzumab Plus First-Line Platinum-Doublet Chemotherapy for Advanced Squamous Cell Non–Small-Cell Lung Cancer

Hirsch, F. R., Govindan, R., Zvirbule, Z., Braiteh, F., Rittmeyer, A., Belda-Iniesta, C., Isla, D., Cosgriff, T., Boyer, M., Ueda, M., Phan, S. & Gandara, D. R., Jan 1 2017, In : Clinical Lung Cancer. 18, 1, p. 43-49 7 p.

Research output: Contribution to journalArticle

13 Scopus citations

Efficacy of the PARP inhibitor veliparib with carboplatin or as a single agent in patients with germline BRCA1- or BRCA2-associated metastatic breast cancer: California Cancer Consortium trial NCT01149083

Somlo, G., Frankel, P. H., Arun, B. K., Ma, C. X., Garcia, A. A., Cigler, T., Cream, L. V., Harvey, H. A., Sparano, J. A., Nanda, R., Chew, H. K., Moynihan, T. J., Vahdat, L. T., Goetz, M. P., Beumer, J. H., Hurria, A., Mortimer, J., Piekarz, R., Sand, S., Herzog, J. & 7 others, Van Tongeren, L. R., Ferry-Galow, K. V., Chen, A. P., Ruel, C., Newman, E. M., Gandara, D. R. & Weitzel, J. N., Aug 1 2017, In : Clinical Cancer Research. 23, 15, p. 4066-4076 11 p.

Research output: Contribution to journalArticle

42 Scopus citations

Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers

Blakely, C. M., Watkins, T. B. K., Wu, W., Gini, B., Chabon, J. J., McCoach, C. E., McGranahan, N., Wilson, G. A., Birkbak, N. J., Olivas, V. R., Rotow, J., Maynard, A., Wang, V., Gubens, M. A., Banks, K. C., Lanman, R. B., Caulin, A. F., St John, J., Cordero, A. R., Giannikopoulos, P. & 9 others, Simmons, A. D., Mack, P., Gandara, D. R., Husain, H., Doebele, R. C., Riess, J., Diehn, M., Swanton, C. & Bivona, T. G., Dec 1 2017, In : Nature Genetics. 49, 12, p. 1693-1704 12 p.

Research output: Contribution to journalArticle

143 Scopus citations
2 Scopus citations

Integrated metabolomics and proteomics highlight altered nicotinamide and polyamine pathways in lung adenocarcinoma

Fahrmann, J. F., Grapov, D., Wanichthanarak, K., DeFelice, B. C., Salemi, M. R., Rom, W. N., Gandara, D. R., Phinney, B. S., Fiehn, O., Pass, H. & Miyamoto, S., Mar 1 2017, In : Carcinogenesis. 38, 3, p. 271-280 10 p.

Research output: Contribution to journalArticle

30 Scopus citations

Paired Phase II Studies of Erlotinib/Bevacizumab for Advanced Bronchioloalveolar Carcinoma or Never Smokers With Advanced Non-Small-cell Lung Cancer: SWOG S0635 and S0636 Trials

West, H. L., Moon, J., Wozniak, A. J., Mack, P., Hirsch, F. R., Bury, M. J., Kwong, M., Nguyen, D. D., Moore, D. F., Miao, J., Redman, M., Kelly, K. & Gandara, D. R., 2017, (Accepted/In press) In : Clinical Lung Cancer.

Research output: Contribution to journalArticle

2 Scopus citations